Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP206937.RAn7JvFKtAmWQ1yh7JVJxd9BbkmkWSZjb9rRr9pQdy4rY130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206937.RAn7JvFKtAmWQ1yh7JVJxd9BbkmkWSZjb9rRr9pQdy4rY130_provenance.
• NP595523.RAtcchPnGVOlGXlfjbA64YhyAHUQ99owUlXBMraCU01ps130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595523.RAtcchPnGVOlGXlfjbA64YhyAHUQ99owUlXBMraCU01ps130_provenance.
• NP752799.RA_iQ_hfahCAtn8xnRa0ytyLTMr-Npw0OgHpp6zHemQZk130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752799.RA_iQ_hfahCAtn8xnRa0ytyLTMr-Npw0OgHpp6zHemQZk130_provenance.
• NP794877.RAPt_dUb4dGvs_9B8oLTjy6ez3BdAqqu6LadFjFR-WxOQ130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794877.RAPt_dUb4dGvs_9B8oLTjy6ez3BdAqqu6LadFjFR-WxOQ130_provenance.
• NP620824.RAfePKujyiFmhMvM3njHZRCWiatsWeBPb3mRHMhYiINds130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620824.RAfePKujyiFmhMvM3njHZRCWiatsWeBPb3mRHMhYiINds130_provenance.
• NP623580.RAdNnCGK7YuyKQMHVVxozim_Lob9Px2ucIElwgmTWkKfI130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623580.RAdNnCGK7YuyKQMHVVxozim_Lob9Px2ucIElwgmTWkKfI130_provenance.
• NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622265.RA5D0ZGK5AFjjTq_ar6Ssc2fpSZc0QnPME43YGKXaCQuI130_provenance.
• NP954474.RA9eLu0GU2V0QBtfNc0WqNJwPGtE10BjmvIvVIHIvr7Qs130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954474.RA9eLu0GU2V0QBtfNc0WqNJwPGtE10BjmvIvVIHIvr7Qs130_provenance.
• NP954469.RAZElPicITXnuqNsA1pe75uu-JzR-7KFLHYe2gQVH_lz4130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954469.RAZElPicITXnuqNsA1pe75uu-JzR-7KFLHYe2gQVH_lz4130_provenance.
• NP954471.RAXdPBY2fYlI1SkcjUhdCarhVu_T2PnmIW_BB9YipIeew130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954471.RAXdPBY2fYlI1SkcjUhdCarhVu_T2PnmIW_BB9YipIeew130_provenance.
• NP624708.RAJ82BW4wvvAVZ7C17U2VUMa3mx7C9WTEkUJ4jDDpJ3Ek130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624708.RAJ82BW4wvvAVZ7C17U2VUMa3mx7C9WTEkUJ4jDDpJ3Ek130_provenance.
• assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP954468.RAtK6-YNq_Vl3eRmtH4abHcsMm1fI3PdCe0oJNJajl4zg130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954468.RAtK6-YNq_Vl3eRmtH4abHcsMm1fI3PdCe0oJNJajl4zg130_provenance.
• NP954470.RAux64j0p0Xzrj5Yc-uaV9ei8yJZ-zl73T7534QJ_o2as130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954470.RAux64j0p0Xzrj5Yc-uaV9ei8yJZ-zl73T7534QJ_o2as130_provenance.
• NP954473.RAnQh69LK93fgsFKZy8aHdeLh-zFj5vt5bjDV8xPl4Apg130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954473.RAnQh69LK93fgsFKZy8aHdeLh-zFj5vt5bjDV8xPl4Apg130_provenance.
• NP954467.RAFaMOcE_YgyioqEnWRkP-YbqMvGBRT9IXQRsiO2usWtQ130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954467.RAFaMOcE_YgyioqEnWRkP-YbqMvGBRT9IXQRsiO2usWtQ130_provenance.
• NP954472.RAPyeiu_yeTBbS4xdpA_s105Heg3jtbQt7HrOIMQiEyBI130_assertion description "[PI3K pathway activation may drive tumorigenesis in a subset of MCC and screening these tumors for PIK3CA mutations could help identify patients who may respond to treatment with PI3K pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954472.RAPyeiu_yeTBbS4xdpA_s105Heg3jtbQt7HrOIMQiEyBI130_provenance.